Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999American Medical Association
Chicago—As therapeutic strategies for Alzheimer disease (AD) begin to emerge, interest has focused on identifying signs of mental decline as early as possible to prevent, delay, or reverse disease-associated brain damage. Experts in the field say a condition known as mild cognitive impairment (MCI), which precedes development of AD and other dementias in many people, appears to be a signal of disease onset that will help target individuals for early interventions.
Friedrich MJ. Mild Cognitive Impairment Raises Alzheimer Disease Risk. JAMA. 1999;282(7):621–622. doi:10.1001/jama.282.7.621-JMN0818-2-1
Customize your JAMA Network experience by selecting one or more topics from the list below.